Tuesday 20 May 2025

Pharma & Biotech Start-up & Scale-up News

Featured

Applied Therapeutics
A clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need.
Pharmaceutical
Lexicon Pharma soars as it licenses LX9851 to Novo Nordisk
28 March 2025
Pharmaceutical
Lexicon pivots back to pipeline after FDA rejection
25 November 2024

Latest Ones To Watch News

Biotechnology
CRISPR and Sirius collaborate on siRNA therapies
20 May 2025
Biotechnology
Don Haut brought in to head business at Arbor
19 May 2025
Biotechnology
CellCentric secures $120 million investment
19 May 2025
More ones to watch news >
Reset all filters
Refine Search
Neurocrine Biosciences
Axsome Therapeutics
Axsome Therapeutics
Cidara Therapeutics
Halda Therapeutics
Opthea
OncoZenge
Soleno Therapeutics
GAIA
Alligator Bioscience
Pliant Therapeutics
Nuvation Bio
Enanta Pharmaceuticals
Basilea
Exsilio Therapeutics
Aphaia Pharma
Avextra
Aurion Biotech
āshibio
UTILITY Therapeutics
Enlaza Therapeutics


Today's issue

GSK’s Blenrep combination approved by Japan MHLW
Biotechnology
GSK’s Blenrep combination approved by Japan MHLW
20 May 2025
Biotechnology
IL-5 biologics well-positioned to expand respiratory reach, analyst says
20 May 2025
Pharmaceutical
MHRA launches new regulations on real-world clinical trials data
20 May 2025
Pharmaceutical
Boehringer’s nerandomilast shows modest benefit in IPF
20 May 2025
Biotechnology
CRISPR and Sirius collaborate on siRNA therapies
20 May 2025
Pharmaceutical
MHRA: what we're doing to cement the UK's position as a world leader in clinical research
20 May 2025
Biotechnology
Don Haut brought in to head business at Arbor
19 May 2025

Company Spotlight

A clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need.




Copyright © The Pharma Letter 2025   |   Headless Content Management with Blaze